ArticleDiabetes2015

Reversal of New-Onset Type 1 Diabetes With an Agonistic TLR4/MD-2 Monoclonal Antibody.

Kyle J Bednar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.